NewSelf Review

Best for: lowest-cost compounded GLP-1 with pharmacy quality transparency

NewSelf offers compounded semaglutide+ (with B12/Glycine, from $99.97/mo) and compounded tirzepatide+ (with B6/Glycine, from $144.49/mo). LegitScript certified. Available in 48 states + Puerto Rico. Uses 503A licensed pharmacies with third-party testing.

By Eli Marsden · Founding Editor
Editorially reviewed (not clinically reviewed) · How we verify contentLast reviewed

High confidence · Last verified 2026-04-10 via manual · How we verify provider data

7.8
★★★3.9
Compounded SemaglutideCompounded TirzepatideB12 + Glycine EnhancedLegitScript Verified503A Pharmacies

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

The Bottom Line

NewSelf is one of the most affordable GLP-1 options on the market.

Score: 7.8/10Best for: lowest-cost compounded GLP-1 with pharmacy quality transparencyFrom: $100/mo

Score Breakdown

Value
8.5
Effectiveness
7.5
User Experience
7.5
Trust & Safety
8
Accessibility
8
Support
7

Drugs Offered

NewSelf prescribes the following GLP-1 medications. Tap a drug to read our clinical guide with FDA label info, dosing schedules, side effects, and trial data.

Pricing

DoseFormPrice/mo
Semaglutide+ (best price)compounded$100
Semaglutide+ (regular)compounded$135
Tirzepatide+ (best price)compounded$144
Tirzepatide+ (regular)compounded$225

Pros

  • Semaglutide+ from $99.97/mo — among the lowest prices in the dataset
  • All dosages at the same price — no price escalation as dose increases
  • LegitScript certified with 503A licensed pharmacies
  • Third-party potency, sterility, and endotoxicity testing
  • 48 states + Puerto Rico coverage
  • B12/B6 + Glycine enhanced formulations
  • No membership fees

Cons

  • Not available in Mississippi and Louisiana
  • Compounded only — no brand-name options
  • Site also promotes AI health optimization and longevity (broader platform)

Ready to start with NewSelf?

Starting at $100/month. See current pricing and start your free consultation.

Sources & methodology

Our NewSelf review applies the same 6-dimension scoring framework we use for every provider. Pricing, FDA approval status, compounding rules, and clinical-trial efficacy claims are sourced from the primary regulatory and peer-reviewed literature below.

Sources & methodology — as of May 2026
  1. 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)WeightLossRankings.org.
  2. 2.FDA — Compounding and the 503A Pharmacy FrameworkU.S. Food & Drug Administration.
  3. 3.FDA — Drug Shortages Database (current shortage listings)U.S. Food & Drug Administration.
  4. 4.PCAB — Pharmacy Compounding Accreditation Board StandardsAccreditation Commission for Health Care (ACHC) / PCAB.
  5. 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)Kaiser Family Foundation.
  6. 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)New England Journal of Medicine.PMID: 33567185.
  7. 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDAU.S. Food & Drug Administration.
  8. 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDAU.S. Food & Drug Administration.
  9. 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)New England Journal of Medicine.PMID: 35658024.
  10. 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDAU.S. Food & Drug Administration.
  11. 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDAU.S. Food & Drug Administration.
  12. 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)New England Journal of Medicine.PMID: 40334173.

Alternatives to NewSelf

7.6/ 10

Belle Health

Best for: Cost-sensitive patients comfortable with the Feb-2026 FDA warning, wanting flat-rate pricing and dietitian-included support

★★★3.8

Editorial score · methodology

$119/mo
CompoundedSemaglutideTirzepatideFDA Warning
Get StartedRead full Belle Health review →
7.1/ 10

bmiMD

Best for: mainstream telehealth GLP-1 access

★★★3.6

Editorial score · methodology

Get StartedRead full bmiMD review →
7.3/ 10

Breeze Meds

Best for: compounded GLP-1 access with named prescribers and 4-pharmacy network

★★★3.7

Editorial score · methodology

$199/mo
CompoundedSemaglutideTirzepatideLegitScript Verified
Get StartedRead full Breeze Meds review →

Frequently Asked Questions

Glossary references

Key terms in this article, linked to their canonical definitions.

Ready to start with NewSelf?

Starting at $100/month. See current pricing and start your free consultation.